M. Jonathan Fray

900 total citations
47 papers, 672 citations indexed

About

M. Jonathan Fray is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, M. Jonathan Fray has authored 47 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Organic Chemistry, 20 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in M. Jonathan Fray's work include Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (5 papers). M. Jonathan Fray is often cited by papers focused on Synthetic Organic Chemistry Methods (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (5 papers). M. Jonathan Fray collaborates with scholars based in United Kingdom, United States and Ireland. M. Jonathan Fray's co-authors include Alan Stobie, Barry M. Trost, Florian Wakenhut, Gavin A. Whitlock, M. J. PARRY, Kelvin Cooper, Paul V. Fish, John Steele, Kenneth Richardson and Nicholas L. Occleston and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

M. Jonathan Fray

47 papers receiving 643 citations

Peers

Countries citing papers authored by M. Jonathan Fray

Since Specialization

Citations

This map shows the geographic impact of M. Jonathan Fray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jonathan Fray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jonathan Fray more than expected).

Fields of papers citing papers by M. Jonathan Fray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jonathan Fray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jonathan Fray. The network helps show where M. Jonathan Fray may publish in the future.

Co-authorship network of co-authors of M. Jonathan Fray

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jonathan Fray. A scholar is included among the top collaborators of M. Jonathan Fray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jonathan Fray. M. Jonathan Fray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Passing on the medicinal chemistry baton: training undergraduates to be industry-ready through research projects between the University of Nottingham and GlaxoSmithKline 2016 ·Drug Discovery Today ·Simon J. F. Macdonald, M. Jonathan Fray, (unknown)	9
2	A practical drug discovery project at the undergraduate level 2013 ·Drug Discovery Today ·M. Jonathan Fray, Simon J. F. Macdonald, (unknown), (unknown), Jack A. Brown, Ian B. Campbell, Ian Churcher, Diane M. Coe, Anthony W. J. Cooper, (unknown), Gail Fisher, Graham G. A. Inglis, (unknown), John Liddle, Aoife C. Maxwell, Vipulkumar K. Patel, Stephen Swanson, (unknown)	11
3	A flexible synthesis of C-6 and N-1 analogues of a 4-amino-1,3-dihydroimidazo[4,5-c]pyridin-2-one core 2011 ·Tetrahedron Letters ·Duncan A. Hay, (unknown), Gerwyn Bish, (unknown), Rachel Dixon, M. Jonathan Fray, James R. Hitchin, Peter Jones, Michael Paradowski, (unknown), (unknown), David C. Pryde, (unknown), Thien-Duc Tran	3
4	Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: Improving metabolic stability and reducing ion channel activity 2010 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Paul V. Fish, (unknown), Gerwyn Bish, (unknown), (unknown), Anthony Harrison, Jean-Loïc Le Net, Stephen C. Phillips, (unknown), (unknown), Alan Stobie, Florian Wakenhut, (unknown), (unknown), Gavin A. Whitlock	3
5	N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration 2009 ·Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, (unknown), Paul V. Fish, M. Jonathan Fray, Anthony Harrison, (unknown), Stephen C. Phillips, Alan Stobie, (unknown), (unknown), Gavin A. Whitlock	7
6	4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: Design, synthesis and structure–activity relationships 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, Mark D. Andrews, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	13
7	Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Gavin A. Whitlock, Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut	22
8	N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Florian Wakenhut, Paul V. Fish, M. Jonathan Fray, Ian Gurrell, James E. Mills, Alan Stobie, Gavin A. Whitlock	10
9	N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Paul V. Fish, M. Jonathan Fray, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	13
10	Structure–activity relationships of N-substituted piperazine amine reuptake inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	18
11	N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, Gerwyn Bish, Alan D. Brown, Paul V. Fish, Alan Stobie, Florian Wakenhut, Gavin A. Whitlock	21
12	Synthesis of substituted 5-aminomethyl tetrahydro-isoquinolines and dihydro-isoindoles 2006 ·Tetrahedron ·M. Jonathan Fray, Paul Allen, (unknown), (unknown), (unknown), Tim Evans, Mark L. Lewis, John P. Mathias, (unknown), (unknown), (unknown), Mark H. Stefaniak, (unknown)	5
13	Synthesis of 5-Heterocyclic Substituted Quinazolin-4-ones via 2-Aminobenzonitrile Derivatives 2006 ·Heterocycles ·M. Jonathan Fray, Paul R. Allen, (unknown), (unknown), (unknown), Tim Evans, Mark L. Lewis, John P. Mathias, (unknown), (unknown), (unknown), Mark H. Stefaniak, (unknown)	7
14	Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3′ group chirality 2001 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, (unknown), (unknown)	19
15	Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (Stromelysin-1) 2001 ·Bioorganic & Medicinal Chemistry Letters ·M. Jonathan Fray, (unknown)	19
16	Application of epimerisation-free amide coupling conditions to the synthesis of matrix metalloprotease inhibitor intermediates 1998 ·Tetrahedron ·M. Jonathan Fray, David Ellis	8
17	Facile Decarboxylation of Nitrobenzeneacetic Acids as a Convenient Route to Alkylnitrobenzenes 1996 ·Synlett ·(unknown), M. Jonathan Fray, (unknown), (unknown)	15
18	1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives 1992 ·Journal of Medicinal Chemistry ·Kelvin Cooper, M. Jonathan Fray, M. J. PARRY, Kenneth Richardson, John Steele	82
19	Stereoselective addition of benzonitrile oxide and N-benzyl-C-phenylnitrone to (5RS,6SR)-5,6-dihydro-6-ethyl-5-methylpyran-2(2H)-one. Crystal structure of (1RS,4RS,5RS,6RS,9SR)-8-benzyl-1,5-dimethyl-4-ethyl-9-phenyl-3,7-dioxa-8-azabicyclo [4.3.0]nonan-2-one. 1985 ·Journal of the Chemical Society Perkin Transactions 1 ·M. Jonathan Fray, Eric J. Thomas, David J. Williams	12
20	An approach to lankacidin synthesis: control of stereochemistry using Δ2-isoxazolines 1984 ·Tetrahedron ·M. Jonathan Fray, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact